| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1974* | 2021 |
| The evidence for soybean products as cancer preventive agents AR Kennedy The Journal of nutrition 125, 733S-743S, 1995 | 506 | 1995 |
| Chemopreventive agents: protease inhibitors AR Kennedy Pharmacology & therapeutics 78 (3), 167-209, 1998 | 481 | 1998 |
| Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study DN Wijeysundera, RM Pearse, MA Shulman, TEF Abbott, E Torres, ... The Lancet 391 (10140), 2631-2640, 2018 | 475 | 2018 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 468* | 2021 |
| The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent AR Kennedy The American journal of clinical nutrition 68 (6), 1406S-1412S, 1998 | 446 | 1998 |
| Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system ES Diffenderfer, II Verginadis, MM Kim, K Shoniyozov, A Velalopoulou, ... International Journal of Radiation Oncology* Biology* Physics 106 (2), 440-448, 2020 | 438 | 2020 |
| Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. AR Kennedy, M Fox, G Murphy, JB Little Proceedings of the National Academy of Sciences 77 (12), 7262-7266, 1980 | 347 | 1980 |
| Automated measurement of mouse social behaviors using depth sensing, video tracking, and machine learning W Hong, A Kennedy, XP Burgos-Artizzu, M Zelikowsky, SG Navonne, ... Proceedings of the National Academy of Sciences 112 (38), E5351-E5360, 2015 | 337 | 2015 |
| Second malignant neoplasms and cardiovascular disease following radiotherapy LB Travis, AK Ng, JM Allan, CH Pui, AR Kennedy, XG Xu, JA Purdy, ... Journal of the National Cancer Institute 104 (5), 357-370, 2012 | 295 | 2012 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 280 | 2022 |
| Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group LL Robison, ME Nesbit Jr, HN Sather, C Level, N Shahidi, A Kennedy, ... The Journal of pediatrics 105 (2), 235-242, 1984 | 269 | 1984 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 261 | 2022 |
| Bowman-Birk soybean protease inhibitor as an anticarcinogen. J Yavelow, TH Finlay, AR Kennedy, W Troll Cancer Research 43 (5 Suppl), 2454s-2459s, 1983 | 247 | 1983 |
| Social behaviour shapes hypothalamic neural ensemble representations of conspecific sex R Remedios, A Kennedy, M Zelikowsky, BF Grewe, MJ Schnitzer, ... Nature 550 (7676), 388-392, 2017 | 220 | 2017 |
| The Mouse Action Recognition System (MARS) software pipeline for automated analysis of social behaviors in mice C Segalin, J Williams, T Karigo, M Hui, M Zelikowsky, JJ Sun, P Perona, ... Elife 10, e63720, 2021 | 207 | 2021 |
| Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. J Yavelow, M Collins, Y Birk, W Troll, AR Kennedy Proceedings of the National Academy of Sciences 82 (16), 5395-5399, 1985 | 204 | 1985 |
| Biological effects of space radiation and development of effective countermeasures AR Kennedy Life sciences in space research 1, 10-43, 2014 | 202 | 2014 |
| Timing of the steps in transformation of C3H 10T½ cells by X-irradiation AR Kennedy, J Cairns, JB Little Nature 307 (5946), 85-86, 1984 | 190 | 1984 |
| Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial WB Armstrong, AR Kennedy, XS Wan, TH Taylor, QA Nguyen, J Jensen, ... Clinical Cancer Research 6 (12), 4684-4691, 2000 | 188 | 2000 |
